HARTE HANKS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.99 USD | -1.41% |
|
-1.69% | +2.95% |
Strengths
- With a P/E ratio at 14.04 for the current year and 6.75 for next year, earnings multiples are highly attractive compared with competitors.
- The stock, which is currently worth 2024 to 0.16 times its sales, is clearly overvalued in comparison with peers.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
Ratings chart - Surperformance
Sector: Advertising & Marketing
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +2.95% | 51.37M | - | ||
| -17.34% | 1.77B | B- | ||
| -29.18% | 387M | - | - | |
| +12.09% | 386M | - | - | |
| +37.32% | 193M | C | ||
| +20.56% | 123M | - | - | |
| -50.38% | 115M | - | - | |
| +6.48% | 94.83M | - | - | |
| +60.50% | 89.42M | - | ||
| +35.38% | 75M | C- |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
- Stock Market
- Equities
- HHS Stock
- Ratings Harte Hanks, Inc.